Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(66.7%)
Phase 2
2(33.3%)
6Total
Phase 3(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01644201Phase 3Terminated

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Role: lead

NCT01387126Phase 3Withdrawn

Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program

Role: collaborator

NCT01109199Phase 3Completed

Effects of a Dietary Fibre Supplementation of a Low Calorie Diet on Appetite and Body Weight

Role: collaborator

NCT01108328Phase 3Completed

Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX)

Role: collaborator

NCT00935350Phase 2Completed

Reduction of the Glycemic Index by a Novel Viscous Polysaccharide

Role: collaborator

NCT00801814Phase 2Completed

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Role: collaborator

All 6 trials loaded